Oral BPC 157 Bioavailability and Absorption One key question is the fate of oral bpc 157 in the digestive tract
Despite contacting the clinic twice, I couldnt confirm current availability
On the other hand, Structure Therapeutics, Viking Therapeutics, AstraZeneca and Merck & Co., Inc
What data currently exists on the impact of GLP-1s on menstrual cycles, ovulation, fertility, or menopause symptoms
Conversely, venglustat, a glucosylceramide synthase inhibitor, failed to show any clinical benefit over placebo in GBA1-related PD in part 2 of a recent phase 2 trial [126], after having demonstrated favourable safety, tolerability, and target engagement in the cerebrospinal fluid (CSF) in part 1 of the same trial [127]